NIFTY 23165.70 BANK 50827.50

Glenmark Pharmaceuticals Ltd.
Share Price Target & Analysis

NSE:GLENMARK

1529

VWAP

1540

Open

1541.05

Close

1558.3

High

1498.15

Low

1830.95

52 Week High

1509.20 ⇩
-31.85 (-2.07%)

GLENMARK

(PHARMA)
62.4% Momentum

Sideways to Positive

975

52 Week Low

215.33

EPS

45.98

PE

1.78

PB

Deluxe
Quality

Steel
Valuation

#Analysis

NSE: GLENMARK Share Price Financial Analysis & Valuation

Glenmark Pharmaceuticals Ltd. (GLENMARK) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Mid Cap company with Market Capitalization of Rs 13448.1 (in Cr). Total number of free float shares are 0 (in Lacs). Glenmark Pharmaceuticals Ltd. is listed on NSE with Exchange ID - INE935A01035 and trading code is NSE:GLENMARK with short name Glenmark.

Glenmark Pharmaceuticals Ltd. is also traded in Future & Options (Derivative segment of NSE).

In the past 1 year, Glenmark Pharmaceuticals Ltd. has declared an equity dividend of Rs 2.5 per share. At the current share price of GLENMARK at Rs 1509.20, this results in a dividend yield of 0.17 %.

As per the Fundamental Analysis of NSE:GLENMARK, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine GLENMARK underlying value and future prospects. All of this data is available in GLENMARK financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:GLENMARK, it is clearly understood that GLENMARK is Deluxe performer in terms of earnings and profit margins with an EPS of 215.33. NSE:GLENMARK book value per share as of today is 848.58. The current price to book ratio for GLENMARK as of Apr 02, 2025 is 1.78.

Valuation of the Stock: The current valuation of GLENMARK stock is like Steel which means currently the stock is Moderately Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of GLENMARK whether to BUY this stock at current valuation. The delivery percentage of GLENMARK is 43.9% is very crucial parameter which shows that 43.9% investors are anticipating that the price of GLENMARK share should go up with VWAP at 1529.

Now, the main question is whether to BUY or SELL, NSE:GLENMARK at current valuation.
As per latest Analysis No. #1051:-

⇑ STRONG BUY GLENMARK if All Greens

⇗ BUY GLENMARK (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD GLENMARK (With Stop Loss) if only 1 Green

⇘ SELL GLENMARK if NO Green Indicator

NSE: GLENMARK Share Price Today (Apr 02, 2025)

(Glenmark Pharmaceuticals Ltd. Daily Analysis on the basis of GLENMARK Intraday Graph & Trend)

Glenmark Pharmaceuticals Ltd. share price moved Down by -2.07% from its previous close of Rs 1541.05. GLENMARK stock last traded price is 1509.20. GLENMARK share price trend is Down with a total of 360057 stocks traded till now. It has touched an intraday high of Rs 1558.3 and an intraday low of Rs 1498.15. The GLENMARK trading at 1509.20, Down by Rs. -31.85, or -2.07 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Down.

NSE: GLENMARK Share Price Tomorrow Prediction

(Glenmark Pharmaceuticals Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of GLENMARK)

Glenmark Pharmaceuticals Ltd. share price moved Down by -2.07%. GLENMARK share price short term trend is Down. It suggests that GLENMARK Share Price for Tomorrow remains the same with VWAP at 1529 will be treated as stop loss for intraday traders. Glenmark Pharmaceuticals Ltd. Long term investors can follow the GLENMARK long term trend as mentiond in future forecast table.

NSE Code

NSE: GLENMARK

GLENMARK Share Price Today

 1509.20

GLENMARK Share Price Target Prediction for 2025 ^

 1396.6 - 1937.7

GLENMARK Share Price Target Prediction for 2026*^

 1937.7 - 2064.3

GLENMARK Share Price Target Prediction for 2027*^

 2064.3 - 2208.8

GLENMARK Share Price Target Prediction for 2028*^

 2319

GLENMARK Share Price Target Prediction for 2029*^

 2386

GLENMARK Share Price Target Prediction for 2030*^

 2600
GLENMARK Current Book Value 2024
844.3

*Glenmark Pharmaceuticals Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^GLENMARK share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

GLENMARK Technical Analysis

Candlestick Pattern: @1325.15

GLENMARK Moving Averages

BUY (0) NEUTRAL (0) SELL (14)
MA Simple Action S1 Expo Action E2
MA_5 1344.73 SELL 1340.15 SELL
MA_12 1403.23 SELL 1381.76 SELL
MA_20 1419.69 SELL 1406.12 SELL
MA_32 1447.46 SELL 1440.62 SELL
MA_50 1490.62 SELL 1468.24 SELL
MA_100 1534.8 SELL 1498.07 SELL
MA_200 1486.46 SELL 1425.86 SELL

GLENMARK Trend Oscillators

BUY (1) NEUTRAL (0) SELL (3)
Trend Oscillators Value Action
Bollinger Bands 1419.69 Downtrend
MACD -9.96 SELL
ADX 30.15 Strong Trend
DMI (+/-) 11.12 / 34.35 Downtrend

GLENMARK Momentum Oscillators

BUY (0) NEUTRAL (7) SELL (5)
Momentum Oscillators Value Action
RSI 36.93 Neutral
STOCHASTIC_K (Fast) 34.9 Neutral
STOCHASTIC_D (Slow) 36.56 Neutral
CCI -96.89 Neutral
PSAR 1469.01 SELL
TRUE RANGE 73.5 SELL
ATR 58.02 SELL
WILLIAMS R -83.58 Oversold
TRIX 0 Neutral
STOCHASTIC RSI K 54.25 Neutral
STOCHASTIC RSI D 39.5 Neutral
MOMENTUM -75.25 SELL

GLENMARK Last 1 Year Trend

Duration Value
1 Year 45.23%
3 Months -11.09%
1 Month -5.37%
1 Week -3.54%

GLENMARK Technical Analysis Summary

Updated on 2025-02-24
Action Overall (%)
BUY 3%
NEUTRAL / HOLD 23%
SELL 73%

Most popular Questions & Answers about GLENMARK


Glenmark Pharmaceuticals Ltd. stock last traded price is 1509.20. GLENMARK share price moved Down by -2.07% from its previous close of Rs 1541.05.

Glenmark Pharmaceuticals Ltd. share price trend is Down with a total of 360057 stocks traded till now. It has touched an intraday high of Rs 1947.44725 and an intraday low of Rs 1498.15. The GLENMARK trading at 1509.20, Down by Rs. -31.85, or -2.07 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Down and the Stop Loss will be around 1529.

The market cap of Glenmark Pharmaceuticals Ltd. is ₹13448.1 (in Cr) as of Apr 01, 2025.

The current price to earning ratio for Glenmark Pharmaceuticals Ltd. as of Apr 01, 2025 is 45.98.

The current price to book ratio for Glenmark Pharmaceuticals Ltd. as of Apr 01, 2025 is 1.78.

The highest price of Glenmark Pharmaceuticals Ltd. stock is ₹1830.95 in the last 52-week.

The lowest price of Glenmark Pharmaceuticals Ltd. stock is ₹975 in the last 52-week.

Glenmark Pharmaceuticals Ltd. share trading at ₹1509.20, Down by Rs. -31.85, or -2.07 percent which suggests that most of the traders are anticipating that the price of GLENMARK share should go Down.

In 2023, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹1396.6 on downside and ₹1937.7 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on current financial year earings of the company.

In 2024, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹1937.7 on downside and ₹2064.3 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on forecasted future earnings of the company.

In 2025, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹2064.3 on downside and ₹2208.8 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) will be around ₹2386 Glenmark Pharmaceuticals Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of GLENMARK.

The price of Glenmark Pharmaceuticals Ltd. (GLENMARK) shares moved by -2.07%. The short-term trend for GLENMARK share price is Down. It implies that the share price of GLENMARK will stay the same tomorrow and that intraday traders should treat VWAP at 1529 as a stop loss. Investors with a long-term outlook can track GLENMARK long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of GLENMARK stock is 2581.8. Compared to the current market price of 1509.20 INR, the GLENMARK stock is Undervalued by 41.5%.

As per the fundamental analysis of Glenmark Pharmaceuticals Ltd. (GLENMARK), it is of Deluxe quality in terms of earnings and profit margins with an EPS of 215.33. Glenmark Pharmaceuticals Ltd. book value per share as of today is 848.58. The current price to book ratio for GLENMARK as of Apr 02, 2025 is 1.78.


NSE:GLENMARK News & Other Useful Information about GLENMARK Share Price


Peer Comparison of NSE: GLENMARK

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1698.30 13.13 98.33
DIVISLAB 5545.00 78.09 513.62
MEDICAMEQ 493.55 7.98 173.4
CIPLA 1447.00 58.33 360.74
DRREDDY 1150.00 62.12 322.46
PGHH 15925.70 189.8 324.25
TORNTPHARM 3180.90 53.89 222.38
BIOCON 339.10 5.01 90.7
LUPIN 1955.40 67.15 481.38
ALKEM 4835.55 194.78 984.46
Updated at: 01 Apr 2025 15:31

Feel free to contact us, in case of any queries.

SITEMAP 1663
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2340.00 24.20 (1.04%) | ADANIGREEN 923.00 -25.65 (-2.7%) | ADANIPORTS 1176.50 -6.45 (-0.55%) | ADANITRANS 1010.05 -18.55 (-1.8%) | AMBUJACEM 530.00 -8.35 (-1.55%) | APOLLOHOSP 6632.30 16.10 (0.24%) | ASIANPAINT 2316.70 -23.95 (-1.02%) | ATGL 593.70 -8.90 (-1.48%) | AUROPHARMA 1134.15 -26.35 (-2.27%) | AXISBANK 1085.20 -16.80 (-1.52%) | BAJAJ-AUTO 7975.00 96.15 (1.22%) | BAJAJFINSV 1941.90 -65.45 (-3.26%) | BAJFINANCE 8719.35 -226.25 (-2.53%) | BALKRISIND 2523.55 -31.25 (-1.22%) | BANDHANBNK 149.55 3.27 (2.24%) | BANKBARODA 228.58 0.05 (0.02%) | BEL 292.00 -9.32 (-3.09%) | BERGEPAINT 494.00 -6.20 (-1.24%) | BHARTIARTL 1723.60 -9.80 (-0.57%) | BIOCON 339.10 -2.60 (-0.76%) | BOSCHLTD 27884.10 -474.35 (-1.67%) | BPCL 285.70 7.23 (2.6%) | BRITANNIA 4905.70 -31.20 (-0.63%) | CADILAHC 1100.00 -15.15 (-1.36%) | CIPLA 1447.00 4.80 (0.33%) | COALINDIA 398.00 -0.20 (-0.05%) | COLPAL 2350.00 -39.80 (-1.67%) | DABUR 497.60 -8.90 (-1.76%) | DIVISLAB 5545.00 -230.45 (-3.99%) | DLF 662.50 -18.00 (-2.65%) | DMART 4016.00 -67.20 (-1.65%) | DRREDDY 1150.00 5.80 (0.51%) | EICHERMOT 5301.15 -46.55 (-0.87%) | GAIL 186.15 3.11 (1.7%) | GLAND 1554.00 -38.40 (-2.41%) | GODREJCP 1146.80 -12.45 (-1.07%) | GRASIM 2612.05 0.90 (0.03%) | GUJGASLTD 409.80 -2.55 (-0.62%) | HAVELLS 1500.00 -28.90 (-1.89%) | HCLTECH 1534.50 -58.00 (-3.64%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 3980.00 -33.90 (-0.84%) | HDFCBANK 1769.90 -58.30 (-3.19%) | HDFCLIFE 693.00 7.30 (1.06%) | HEROMOTOCO 3762.05 39.10 (1.05%) | HINDALCO 663.50 -18.95 (-2.78%) | HINDUNILVR 2237.00 -21.85 (-0.97%) | HINDZINC 453.55 -8.35 (-1.81%) | ICICIBANK 1318.15 -30.20 (-2.24%) | ICICIGI 1796.00 3.15 (0.18%) | ICICIPRULI 571.10 6.75 (1.2%) | INDIGO 5036.00 -79.35 (-1.55%) | INDUSINDBK 682.70 32.85 (5.06%) | INDUSTOWER 352.25 17.95 (5.37%) | INFY 1530.20 -40.45 (-2.58%) | IOB 37.69 -1.28 (-3.28%) | IOC 131.45 3.75 (2.94%) | ITC 406.60 -3.15 (-0.77%) | JSWSTEEL 1060.00 -3.20 (-0.3%) | KOTAKBANK 2144.30 -26.90 (-1.24%) | LT 3438.30 -54.00 (-1.55%) | LTI 6149.30 78.10 (1.29%) | LUPIN 1955.40 -72.55 (-3.58%) | M&M 2640.00 -25.80 (-0.97%) | MARICO 650.00 -1.65 (-0.25%) | MARUTI 11455.25 -66.90 (-0.58%) | MCDOWELL-N 1485.00 -14.35 (-0.96%) | MOTHERSUMI 187.83 -5.36 (-2.77%) | MUTHOOTFIN 2328.00 -54.90 (-2.3%) | NAUKRI 6787.60 -393.80 (-5.48%) | NESTLEIND 2234.90 -15.85 (-0.7%) | NMDC 69.77 0.88 (1.28%) | NTPC 352.95 -4.65 (-1.3%) | ONGC 248.35 1.97 (0.8%) | PEL 989.05 1.20 (0.12%) | PIDILITIND 2829.45 -19.85 (-0.7%) | PIIND 3450.40 22.20 (0.65%) | PNB 96.49 0.36 (0.37%) | POWERGRID 289.10 -1.25 (-0.43%) | RELIANCE 1254.00 -21.10 (-1.65%) | SAIL 116.88 1.70 (1.48%) | SBICARD 860.00 -21.10 (-2.39%) | SBILIFE 1542.30 -5.55 (-0.36%) | SBIN 771.25 -0.25 (-0.03%) | SHREECEM 30081.00 -421.95 (-1.38%) | SIEMENS 5229.00 -46.35 (-0.88%) | SRF 2879.50 -59.65 (-2.03%) | SUNPHARMA 1698.30 -36.40 (-2.1%) | TATACONSUM 992.40 -9.50 (-0.95%) | TATAMOTORS 672.00 -2.45 (-0.36%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 153.25 -0.99 (-0.64%) | TCS 3556.45 -49.70 (-1.38%) | TECHM 1396.50 -21.75 (-1.53%) | TITAN 2988.45 -74.90 (-2.45%) | TORNTPHARM 3180.90 -47.05 (-1.46%) | ULTRACEMCO 11386.80 -122.75 (-1.07%) | UPL 634.50 -1.75 (-0.28%) | VEDL 457.25 -6.15 (-1.33%) | WIPRO 262.25 0.00 (0%) |